JP2022046635A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022046635A5 JP2022046635A5 JP2021210071A JP2021210071A JP2022046635A5 JP 2022046635 A5 JP2022046635 A5 JP 2022046635A5 JP 2021210071 A JP2021210071 A JP 2021210071A JP 2021210071 A JP2021210071 A JP 2021210071A JP 2022046635 A5 JP2022046635 A5 JP 2022046635A5
- Authority
- JP
- Japan
- Prior art keywords
- raav
- gnptab
- aav
- iii
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002245 particle Substances 0.000 claims 14
- 241000702421 Dependoparvovirus Species 0.000 claims 9
- 101001072470 Homo sapiens N-acetylglucosamine-1-phosphotransferase subunits alpha/beta Proteins 0.000 claims 9
- 102100036710 N-acetylglucosamine-1-phosphotransferase subunits alpha/beta Human genes 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 208000008955 Mucolipidoses Diseases 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- 230000008719 thickening Effects 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 230000008488 polyadenylation Effects 0.000 claims 3
- 239000013608 rAAV vector Substances 0.000 claims 3
- 239000013598 vector Substances 0.000 claims 3
- 206010000060 Abdominal distension Diseases 0.000 claims 2
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims 2
- 208000028698 Cognitive impairment Diseases 0.000 claims 2
- 206010010774 Constipation Diseases 0.000 claims 2
- 206010011878 Deafness Diseases 0.000 claims 2
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 claims 2
- 206010072928 Mucolipidosis type II Diseases 0.000 claims 2
- 206010072929 Mucolipidosis type III Diseases 0.000 claims 2
- 206010057190 Respiratory tract infections Diseases 0.000 claims 2
- 102100038413 UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase Human genes 0.000 claims 2
- 108010024501 UDPacetylglucosamine-dolichyl-phosphate acetylglucosamine-1-phosphate transferase Proteins 0.000 claims 2
- 210000000988 bone and bone Anatomy 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 230000003111 delayed effect Effects 0.000 claims 2
- 230000004064 dysfunction Effects 0.000 claims 2
- 230000010370 hearing loss Effects 0.000 claims 2
- 231100000888 hearing loss Toxicity 0.000 claims 2
- 208000016354 hearing loss disease Diseases 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- 210000004115 mitral valve Anatomy 0.000 claims 2
- 210000003205 muscle Anatomy 0.000 claims 2
- 230000000750 progressive effect Effects 0.000 claims 2
- 231100001055 skeletal defect Toxicity 0.000 claims 2
- 206010045458 umbilical hernia Diseases 0.000 claims 2
- 241001655883 Adeno-associated virus - 1 Species 0.000 claims 1
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims 1
- 241000202702 Adeno-associated virus - 3 Species 0.000 claims 1
- 241000580270 Adeno-associated virus - 4 Species 0.000 claims 1
- 241001634120 Adeno-associated virus - 5 Species 0.000 claims 1
- 241000972680 Adeno-associated virus - 6 Species 0.000 claims 1
- 241001164823 Adeno-associated virus - 7 Species 0.000 claims 1
- 241000649045 Adeno-associated virus 10 Species 0.000 claims 1
- 241000649046 Adeno-associated virus 11 Species 0.000 claims 1
- 241000649047 Adeno-associated virus 12 Species 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 241000283707 Capra Species 0.000 claims 1
- 230000037182 bone density Effects 0.000 claims 1
- 108010006025 bovine growth hormone Proteins 0.000 claims 1
- 210000000234 capsid Anatomy 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000001934 delay Effects 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 102000044577 human GNPTAB Human genes 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000004584 weight gain Effects 0.000 claims 1
- 235000019786 weight gain Nutrition 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024019140A JP2024056832A (ja) | 2015-12-15 | 2024-02-13 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562267502P | 2015-12-15 | 2015-12-15 | |
| US62/267,502 | 2015-12-15 | ||
| PCT/US2016/066611 WO2017106313A1 (en) | 2015-12-15 | 2016-12-14 | Adeno-associated viral vectors for treating mucolipidosis type ii |
| JP2018531240A JP7347932B2 (ja) | 2015-12-15 | 2016-12-14 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531240A Division JP7347932B2 (ja) | 2015-12-15 | 2016-12-14 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024019140A Division JP2024056832A (ja) | 2015-12-15 | 2024-02-13 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022046635A JP2022046635A (ja) | 2022-03-23 |
| JP2022046635A5 true JP2022046635A5 (OSRAM) | 2022-12-09 |
Family
ID=57737987
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531240A Active JP7347932B2 (ja) | 2015-12-15 | 2016-12-14 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
| JP2021210071A Pending JP2022046635A (ja) | 2015-12-15 | 2021-12-24 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
| JP2024019140A Pending JP2024056832A (ja) | 2015-12-15 | 2024-02-13 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531240A Active JP7347932B2 (ja) | 2015-12-15 | 2016-12-14 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024019140A Pending JP2024056832A (ja) | 2015-12-15 | 2024-02-13 | ムコリピドーシスｉｉ型を治療するためのアデノ随伴ウイルスベクター |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200261598A1 (OSRAM) |
| EP (1) | EP3390644B1 (OSRAM) |
| JP (3) | JP7347932B2 (OSRAM) |
| KR (1) | KR102833376B1 (OSRAM) |
| CN (1) | CN108603199A (OSRAM) |
| AU (2) | AU2016372035B2 (OSRAM) |
| CA (1) | CA3008268A1 (OSRAM) |
| ES (1) | ES2991277T3 (OSRAM) |
| IL (1) | IL259964B (OSRAM) |
| MX (1) | MX2018007330A (OSRAM) |
| RU (1) | RU2742612C2 (OSRAM) |
| SG (2) | SG10201912935WA (OSRAM) |
| WO (1) | WO2017106313A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11491241B2 (en) | 2017-11-07 | 2022-11-08 | The University Of North Carolina At Chapel Hill | Optimized AGA genes and expression cassettes and their use |
| AU2019385506A1 (en) * | 2018-11-21 | 2021-06-03 | Takeda Pharmaceutical Company Limited | Recombinant viral vectors and nucleic acids for producing the same |
| WO2021077101A1 (en) | 2019-10-18 | 2021-04-22 | Research Institute At Nationwide Children's Hospital | Materials and methods for the treatment of disorders associated mutations in the irf2bpl gene |
| MX2022009883A (es) * | 2020-02-13 | 2022-10-03 | Tenaya Therapeutics Inc | Vectores de genoterapia para tratar enfermedades cardíacas. |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478745A (en) * | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6989264B2 (en) | 1997-09-05 | 2006-01-24 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| HK1039565B (zh) * | 1998-04-27 | 2005-10-21 | Peter M.C. Wong | 治疗内毒素血症的方法 |
| US6642038B1 (en) * | 1999-09-14 | 2003-11-04 | Genzyme Glycobiology Research Institute, Inc. | GlcNAc phosphotransferase of the lysosomal targeting pathway |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| SG10202108118RA (en) | 2001-11-13 | 2021-08-30 | Univ Pennsylvania | A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| EP1497412A4 (en) * | 2002-04-30 | 2006-11-22 | Avior Therapeutics Inc | ADENOVIRUS VECTORS USED IN IMMUNOTHERAPY |
| WO2004075861A2 (en) | 2003-02-26 | 2004-09-10 | Children's Hospital, Inc. | Recombinant adeno-associated virus production |
| US7261544B2 (en) | 2003-05-21 | 2007-08-28 | Genzyme Corporation | Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| US8283151B2 (en) | 2005-04-29 | 2012-10-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes |
| WO2007120542A2 (en) | 2006-03-30 | 2007-10-25 | The Board Of Trustees Of The Leland Stanford Junior University | Aav capsid library and aav capsid proteins |
| PT3252161T (pt) * | 2007-06-06 | 2022-02-01 | Genzyme Corp | Terapia genética para doenças do armazenamento lisossomal |
| KR101812813B1 (ko) | 2009-06-16 | 2017-12-27 | 젠자임 코포레이션 | 재조합 ａａｖ 벡터에 대한 개선된 정제 방법 |
| EP2588130B1 (en) * | 2010-06-25 | 2016-08-17 | Shire Human Genetic Therapies, Inc. | Cns delivery of therapeutic agents |
| US8663624B2 (en) | 2010-10-06 | 2014-03-04 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| SG10202007803QA (en) | 2011-02-17 | 2020-09-29 | Univ Pennsylvania | Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer |
| AU2014229051B2 (en) * | 2013-03-15 | 2020-07-16 | The Children's Hospital Of Philadelphia | Vectors comprising stuffer/filler polynucleotide sequences and methods of use |
| WO2015060722A1 (en) * | 2013-10-24 | 2015-04-30 | Uniqure Ip B.V. | Aav-5 pseudotyped vector for gene therapy for neurological diseases |
| EP3137497B2 (en) * | 2014-05-02 | 2025-03-05 | Genzyme Corporation | Aav vectors for retinal and cns gene therapy |
-
2016
- 2016-12-14 RU RU2018124448A patent/RU2742612C2/ru active
- 2016-12-14 SG SG10201912935WA patent/SG10201912935WA/en unknown
- 2016-12-14 CA CA3008268A patent/CA3008268A1/en active Pending
- 2016-12-14 ES ES16822578T patent/ES2991277T3/es active Active
- 2016-12-14 MX MX2018007330A patent/MX2018007330A/es unknown
- 2016-12-14 JP JP2018531240A patent/JP7347932B2/ja active Active
- 2016-12-14 US US16/061,579 patent/US20200261598A1/en active Pending
- 2016-12-14 WO PCT/US2016/066611 patent/WO2017106313A1/en not_active Ceased
- 2016-12-14 SG SG11201804994QA patent/SG11201804994QA/en unknown
- 2016-12-14 KR KR1020187019970A patent/KR102833376B1/ko active Active
- 2016-12-14 EP EP16822578.7A patent/EP3390644B1/en active Active
- 2016-12-14 CN CN201680081705.8A patent/CN108603199A/zh active Pending
- 2016-12-14 AU AU2016372035A patent/AU2016372035B2/en active Active
- 2016-12-14 IL IL259964A patent/IL259964B/en unknown
-
2021
- 2021-12-24 JP JP2021210071A patent/JP2022046635A/ja active Pending
-
2023
- 2023-06-28 AU AU2023204116A patent/AU2023204116B2/en active Active
-
2024
- 2024-02-13 JP JP2024019140A patent/JP2024056832A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022068181A5 (OSRAM) | ||
| JP2021087431A5 (OSRAM) | ||
| JP2024009857A5 (OSRAM) | ||
| JP2021523718A5 (OSRAM) | ||
| JP2025162557A5 (OSRAM) | ||
| JP2019503649A5 (OSRAM) | ||
| JP2021106619A5 (OSRAM) | ||
| JP2021118724A5 (OSRAM) | ||
| JP2017509632A5 (OSRAM) | ||
| JP2021512072A5 (OSRAM) | ||
| JP2018522529A5 (OSRAM) | ||
| JP2020522269A5 (OSRAM) | ||
| EP3807413B1 (en) | Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy | |
| JP2018510648A5 (OSRAM) | ||
| IL320714A (en) | Gene therapy for limb-girdle muscular dystrophy type 2c | |
| HRP20192141T1 (hr) | Genska terapija za retinitis pigmentosa | |
| JP2022547197A5 (OSRAM) | ||
| JP2018506261A5 (OSRAM) | ||
| JP2021523702A5 (OSRAM) | ||
| IL292264B2 (en) | aav transfer cassette | |
| JP2020533276A5 (OSRAM) | ||
| JP2022551744A5 (OSRAM) | ||
| JP2017529395A5 (OSRAM) | ||
| MX2023001419A (es) | Vector viral adenoasociado para la expresion de glut1 y usos de este. | |
| JP2025513851A5 (OSRAM) |